Back to Research Hub
Galapagos N.V.
GLPG
$27.98+0.47 (+1.71%)
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need.
StreetsValue research for Galapagos N.V. (GLPG)
Members get the full report for Galapagos N.V.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.